Present address: The National Centre for Education and Training on Addiction, Flinders University, Adelaide, Australia.
A pilot randomised controlled trial of modafinil during acute methamphetamine withdrawal: Feasibility, tolerability and clinical outcomes
Article first published online: 27 MAY 2012
© 2012 Australasian Professional Society on Alcohol and other Drugs
Drug and Alcohol Review
Volume 32, Issue 1, pages 88–95, January 2013
How to Cite
[A pilot randomised controlled trial of modafinil during acute methamphetamine withdrawal: Feasibility, tolerability and clinical outcomes. Drug Alcohol Rev 2013;32:88–95]., , , , ,
Clinical Trial Registration: Australian New Zealand Clinical Trials Registry—ACTRN12606000272594
- Issue published online: 10 JAN 2013
- Article first published online: 27 MAY 2012
- Manuscript Accepted: 3 MAY 2012
- Manuscript Received: 26 SEP 2011
- 1United Nations Office on Drugs and Crime. World drug report 2009. Vienna: United Nations Office on Drugs and Crime, 2010.
- 2Australian Institute of Health and Welfare. 2007 National Drug Strategy Household Survey: detailed findings. Drug statistics series No. 22. Cat. No. PHE 107. Canberra: Australian Institute of Health and Welfare, 2008.
- 7American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 4th edn. Washington DC: American Psychiatric Association, 2000.
- 17Treatment for amphetamine withdrawal. Cochrane Database Syst Rev 2009;15:CD003021., , , .
- 26Brain dopamine neurotoxicity in baboons treated with doses of methamphetamine comparable to those recreationally abused by humans: evidence from [11C]WIN-35,428 positron emission tomography studies and direct in vitro determinations. J Neurosci 1998;18:419–427., , , et al.
- 33Missing data: a gentle introduction. In: Mcknight PE , ed. Methodology in the social sciences. New York: Guildford Press, 2007..
- 34Australian Institute of Health and Welfare. Alcohol and other drug treatment services in Australia 2006–07: report on the National Minimum Data Set. Drug treatment series No. 8. Cat. No. HSE 59. Canberra: AIHW, 2008.